Skip to main content
. 2020 Dec 19;8(12):2035. doi: 10.3390/microorganisms8122035

Table 4.

Clinical characteristics and outcomes of non-critically ill and critically ill patients with CRKP bacteriuria.

Variable Non-Critically Ill Patients (APACHI II < 20)
(n = 58)
Critically Ill Patients (APACHI II ≥ 20)
(n = 49)
p Value
Demographics
Age, years, mean ± SD 72.79 ± 15.26 76.67 ± 13.30 0.168
Male sex 33 (56.9) 19 (38.8) 0.062
LOS before CRKP isolation, days, mean ± SD 13.38 ± 20.08 38.67 ± 41.02 <0.001
Carbapenemase-producing CRKP 22 (37.9) 22 (44.9) 0.466
Previous hospitalization 1 33 (56.9) 22 (44.9) 0.216
Comorbidities
Diabetes mellitus 28 (48.3) 30 (61.2) 0.180
COPD 13 (22.4) 6 (12.2) 0.170
Heart failure 9 (15.5) 23 (46.9) <0.001
Cerebrovascular disease 13 (22.4) 24 (49.0) 0.004
Chronic kidney disease 2 26 (44.8) 36 (73.5) 0.003
Liver cirrhosis 1 (1.7) 4 (8.2) 0.177
Malignancy 19 (32.8) 16 (32.7) 0.991
Immunocompromised state 7 (12.1) 5 (10.2) 0.761
Charlson Comorbidity Index, mean ± SD 3.24 ± 2.53 5.10 ± 2.62 <0.001
Indwelling urinary catheter 36 (62.1) 40 (81.6) 0.026
Nasogastric tube 27 (46.6) 44 (89.8) <0.001
Surgical drainage 6 (10.3) 3 (6.1) 0.504
Mechanically ventilated at isolation 3 (5.2) 19 (38.8) <0.001
Renal dialysis at isolation 1 (1.7) 10 (20.4) 0.002
APACHE II score, mean ± SD 12.98 ± 4.20 28.10 ± 6.52 <0.001
Appropriate antimicrobial therapy 20 (34.5) 13 (26.5) 0.375
Clinical outcomes
14-day mortality 2 (3.4) 13 (26.5) 0.001
28-day mortality 8 (13.8) 19 (38.8) 0.003
Shock 0 (0.0) 7 (14.3) 0.003

Data are expressed as No. (%) unless otherwise specified. Abbreviations: SD, standard deviation; LOS, length of hospital stay; COPD, chronic obstructive pulmonary disease; APACHE, Acute Physiology and Chronic Health Evaluation. 1 During the 3 months preceding infection onset. 2 Defined as estimated glomerular filtration rate ≤ 60 mL/min/1.73 m2.